Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | |
|---|---|---|---|---|---|---|
| Total revenue | -48.98%1.89M | 112.09%3.7M | 1.76%1.74M | 15.34%1.71M | 25.86%1.49M | 1.18M |
| Operating revenue | -48.98%1.89M | 112.09%3.7M | 1.76%1.74M | 15.34%1.71M | 25.86%1.49M | --1.18M |
| Cost of revenue | -77.24%357.08K | 607.87%1.57M | -34.95%221.61K | 5.26%340.66K | 20.01%323.63K | 269.67K |
| Gross profit | -28.18%1.53M | 39.95%2.13M | 10.86%1.52M | 18.15%1.37M | 27.59%1.16M | 911.43K |
| Operating expense | 7.88%5.08M | 4.09%4.71M | -14.96%4.53M | 26.56%5.32M | -16.02%4.21M | 5.01M |
| Selling and administrative expenses | 4.51%3.88M | 3.72%3.71M | -8.98%3.58M | 16.70%3.93M | -0.76%3.37M | --3.39M |
| -Selling and marketing expense | 45.02%253.76K | -42.42%174.97K | 32.17%303.87K | 848.22%229.91K | -63.96%24.25K | --67.28K |
| -General and administrative expense | 2.51%3.63M | 8.00%3.54M | -11.53%3.27M | 10.67%3.7M | 0.52%3.34M | --3.33M |
| Depreciation amortization depletion | -3.27%194.9K | 24.85%201.48K | 18.27%161.38K | -4.60%136.45K | 3.87%143.03K | --137.7K |
| -Depreciation and amortization | -3.27%194.9K | 24.85%201.48K | 18.27%161.38K | -4.60%136.45K | 3.87%143.03K | --137.7K |
| Other operating expenses | 26.35%1.01M | 1.52%798.22K | -37.32%786.3K | 80.87%1.25M | -52.99%693.56K | --1.48M |
| Operating profit | -37.67%-3.55M | 14.10%-2.58M | 23.94%-3M | -29.77%-3.95M | 25.72%-3.04M | -4.1M |
| Net non-operating interest income (expenses) | -142.36%-13.3K | 54.16%31.4K | 435.46%20.37K | -21.03%3.8K | -57.49%4.82K | 11.33K |
| Non-operating interest income | -73.57%8.3K | 54.16%31.4K | 435.46%20.37K | -21.03%3.8K | -57.49%4.82K | --11.33K |
| Non-operating interest expense | --21.6K | ---- | ---- | ---- | ---- | ---- |
| Other net income (expenses) | 164.65%14.14K | -115.59%-21.87K | -48.31%140.3K | 44.32%271.41K | -13.86%188.06K | 218.31K |
| Other non-operating income (expenses) | 164.65%14.14K | -115.59%-21.87K | -48.31%140.3K | 44.32%271.41K | -13.86%188.06K | --218.31K |
| Income before tax | -38.15%-3.55M | 9.58%-2.57M | 22.62%-2.84M | -28.89%-3.67M | 26.30%-2.85M | -3.87M |
| Income tax | 4.66%-636.5K | 6.96%-667.6K | -1.94%-717.51K | -12.26%-703.84K | 11.59%-626.96K | -709.14K |
| Earnings from equity interest net of tax | ||||||
| Net income | -53.17%-2.91M | 10.46%-1.9M | 28.44%-2.12M | -33.59%-2.97M | 29.60%-2.22M | -3.16M |
| Net income continuous operations | -53.17%-2.91M | 10.46%-1.9M | 28.44%-2.12M | -33.59%-2.97M | 29.60%-2.22M | ---3.16M |
| Noncontrolling interests | 169.84%48.39K | -198.75%-69.29K | 199.73%70.16K | -55.06%23.41K | 52.09K | |
| Net income attributable to the company | -49.37%-2.91M | 5.09%-1.95M | 32.37%-2.06M | -35.32%-3.04M | 30.02%-2.25M | -3.21M |
| Preferred stock dividends | ||||||
| Other under preferred stock dividend | ||||||
| Net income attributable to common stockholders | -49.37%-2.91M | 5.09%-1.95M | 32.37%-2.06M | -35.32%-3.04M | 30.02%-2.25M | -3.21M |
| Diluted earnings per share | -14.10%-0.0089 | 29.09%-0.0078 | 43.88%-0.011 | -19.51%-0.0196 | 38.35%-0.0164 | -0.0266 |
| Basic earnings per share | -14.10%-0.0089 | 29.09%-0.0078 | 43.88%-0.011 | -19.51%-0.0196 | 38.35%-0.0164 | -0.0266 |
| Dividend per share | ||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |